Insmed (INSM) Amortization - Intangibles (2018 - 2026)
Insmed's (INSM) quarterly Amortization - Intangibles came in at $2.1 million in Q1 2026, up 64.77% year-on-year from $1.3 million in Q1 2025, and up 7.43% quarter-over-quarter from $1.9 million in Q4 2025.
Insmed (INSM) Amortization - Intangibles (2018 - 2026) Analysis & Trends
Insmed's Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Amortization - Intangibles rose 64.77% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $6.8 million, a 34.98% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 18.78% from the prior year.
- Amortization - Intangibles rose to $2.1 million in Q1 2026 per INSM's latest filing, from $1.9 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $2.1 million in Q1 2026 and bottomed at $1.3 million in Q1 2022.
- The 5-year median for Amortization - Intangibles is $1.3 million (2022), against an average of $1.4 million.
- Across the five-year window, Amortization - Intangibles dropped 0.08% in 2022 and soared 64.77% in 2026, its largest moves.
- Year by year, Amortization - Intangibles stood at $1.3 million in 2022, then dropped by 0.08% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then jumped by 53.37% to $1.9 million in 2025, then grew by 7.43% to $2.1 million in 2026.
- Per Business Quant, the three latest INSM Amortization - Intangibles figures stand at $2.1 million (Q1 2026), $1.9 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.26 Mn |
| Jun 30, 2021 | 1.26 Mn |